Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | 2,6-Dichloropyridine | HCID 16989 | — |
| Product | HCID 14654935 | HCID 14654935 | — |
Reaction Steps
A solution of 2,6-dichloropyridine (10 g) and piperazine (25 g) in pyridine (30 ml) is stirred at 65° for 3 h and at 20°-25° overnight. The reaction mixture is concentrated, the residue is partitioned between ether and aqueous potassium carbonate. The organic phase is separated, washed with saline, dried over sodium sulfate and concentrated. The residue is added to pyrrolidine (15 g), pyridine (100 ml) and heated at 100° for 6 days. The reaction mixture is concentrated. The residue is partitioned between methylene chloride and aqueous sodium bicarbonate. The organic phase is separated, dried and concentrated. The residue is chromatographed on silica gel, eluting with methanol/ammonium hydroxide/methylene chloride (15/1/84). The appropriate fractions are pooled and concentrated to give the title compound, NMR (CDCLl3) 1.9, 2.9, 3.4, 5.75, 6.5, 7.3 δ.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05268477 |
|---|
| Source dataset | uspto-grants-1993_12 |
|---|
| ORD ID | ord-3d51f50e7c874a8799740148f63672d4 |
|---|
| Source note | uspto-grants-1993_12 |
|---|